Correction: CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer (Cancers, (2022), 14, 2, (326), 10.3390/cancers14020326)
Lan B, Zeng S, Zhang S, Ren X, Xing Y, Kutschick I, Pfeffer S, Frey B, Britzen-Laurent N, Grützmann R, Cordes N, Pilarsky C (2025)
Publication Type: Journal article, Erratum
Publication year: 2025
Journal
Book Volume: 17
Article Number: 3181
Journal Issue: 19
Abstract
In the original publication [1], there was a mistake in Figure 2C right as published. An error occurred during figure assembly duplicating part of the figure. The corrected Figure 2C right appears below. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Authors with CRIS profile
Bin Lan
Professur für Chirurgische Forschung
Siyuan Zeng
Professur für Chirurgische Forschung
Shuman Zhang
Professur für Chirurgische Forschung
Xiaofan Ren
Professur für Chirurgische Forschung
Yuming Xing
Professur für Chirurgische Forschung
Benjamin Frey
Department of Radiation Oncology
Nathalie Britzen-Laurent
Department of Surgery
Robert Grützmann
Lehrstuhl für Allgemein- und Viszeralchirurgie
Christian Pilarsky
Professur für Chirurgische Forschung
Involved external institutions
Germany (DE)How to cite
APA:
Lan, B., Zeng, S., Zhang, S., Ren, X., Xing, Y., Kutschick, I.,... Pilarsky, C. (2025). Correction: CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer (Cancers, (2022), 14, 2, (326), 10.3390/cancers14020326). Cancers, 17(19). https://doi.org/10.3390/cancers17193181
MLA:
Lan, Bin, et al. "Correction: CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer (Cancers, (2022), 14, 2, (326), 10.3390/cancers14020326)." Cancers 17.19 (2025).
BibTeX: Download